When binarizing subjects according to biomarker positivity in AT profiles, it is possible to observe that individuals without the presence of Alzheimer's disease pathology have significantly lower plasma GFAP levels than patients with Alzheimer's disease pathology. The gene discussed is GFAP; the disease is Alzheimer disease.